MedCap AB (publ) (STO:MCAP)
Sweden · Delayed Price · Currency is SEK 485.00
-4.50 (-0.92%)
At close: Mar 2, 2026
MedCap AB Market Cap
MedCap AB has a market cap or net worth of 7.28 billion as of March 2, 2026. Its market cap has increased by 21.62% in one year.
Market Cap
7.28B
Enterprise Value
7.40B
Revenue
2.11B
Ranking
n/a
PE Ratio
33.07
Stock Price
485.00
Market Cap Chart
Since July 4, 2006, MedCap AB's market cap has increased from 37.25M to 7.28B, an increase of 19,456.28%. That is a compound annual growth rate of 30.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 7.35B | -11.18% |
| Dec 30, 2025 | 8.28B | -6.99% |
| Dec 30, 2024 | 8.90B | 78.07% |
| Dec 29, 2023 | 5.00B | 55.89% |
| Dec 30, 2022 | 3.21B | 21.63% |
| Dec 30, 2021 | 2.64B | -22.55% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Getinge AB | 55.26B |
| Sectra AB | 37.34B |
| Elekta AB | 22.18B |
| Nolato AB | 14.02B |
| Vitrolife AB | 12.92B |
| Xvivo Perfusion AB | 5.91B |
| CellaVision AB | 3.62B |
| BICO Group AB | 1.29B |